These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 30269099

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Botulinum Toxin A for the Treatment of Photophobia and Dry Eye.
    Diel RJ, Kroeger ZA, Levitt RC, Sarantopoulos C, Sered H, Martinez-Barrizonte J, Galor A.
    Ophthalmology; 2018 Jan; 125(1):139-140. PubMed ID: 29110944
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of botulinum toxin type A on the treatment of dry eye disease and tear cytokines.
    Choi MG, Yeo JH, Kang JW, Chun YS, Lee JK, Kim JC.
    Graefes Arch Clin Exp Ophthalmol; 2019 Feb; 257(2):331-338. PubMed ID: 30552510
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Patients With Migraine Have Substantial Reductions in Measures of Visual Quality of Life.
    Hanson LL, Ahmed Z, Katz BJ, Warner JEA, Crum AV, Zhang Y, Zhang Y, Baggaley S, Pippitt K, Cortez MM, Digre KB.
    Headache; 2018 Jul; 58(7):1007-1013. PubMed ID: 29877580
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Reduced Visual Quality of Life Associated with Migraine is Most Closely Correlated with Symptoms of Dry Eye.
    Ozudogru S, Neufeld A, Katz BJ, Baggaley S, Pippitt K, Zhang Y, Digre KB.
    Headache; 2019 Nov; 59(10):1714-1721. PubMed ID: 31557326
    [Abstract] [Full Text] [Related]

  • 14. Botulinum toxin type A for migraine prophylaxis in the Japanese population: an open-label prospective trial.
    Suzuki K, Iizuka T, Sakai F.
    Intern Med; 2007 Nov; 46(13):959-63. PubMed ID: 17603233
    [Abstract] [Full Text] [Related]

  • 15. Botulinum Toxin A Injection for the Treatment of Intractable Dry Eye Disease.
    Choi EW, Yeom DJ, Jang SY.
    Medicina (Kaunas); 2021 Mar 08; 57(3):. PubMed ID: 33800125
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Botulinum toxin A decreases neural activity in pain-related brain regions in individuals with chronic ocular pain and photophobia.
    Reyes N, Huang JJ, Choudhury A, Pondelis N, Locatelli EV, Felix ER, Pattany PM, Galor A, Moulton EA.
    Front Neurosci; 2023 Mar 08; 17():1202341. PubMed ID: 37404468
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Application of botulinum toxin in Horner's muscle for the treatment of dry eye.
    Diaz AL, Chaparro TA, Tello A, Coy H, Frederick GA, Parra MM.
    Arch Soc Esp Oftalmol (Engl Ed); 2018 Dec 08; 93(12):617-620. PubMed ID: 30001848
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.